Dr. Matthew E. Griffith, MD
Infectious Disease (Infectious Disease Physician)
- Medicare participating
At a glance
- Medical school
- Uniformed Services Uhs Fe Hebert School of Med (2001)
- Years since graduation
- 25
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 615
Licensed in Texas since 2020, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2001Medical school: Uniformed Services Uhs Fe Hebert School of Med
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Infectious Disease Physician primary
FL license ME158757 · GA license 052271 · TX license S8832 (first issued 2020; cancelled by request) -
Internal Medicine Physician
FL license ME158757
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Baptist Health Medical Center - Jacksonville Jacksonville, FL
- Baptist Medical Center Beaches Jacksonville Beach, FL
- Ascension St Vincent's Riverside Jacksonville, FL
- Baptist Medical Center - Nassau Fernandina Beach, FL
Medical groups
- Baptist Primary Care Inc (471 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 615
- Services billed
- 1,820
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 461 | 168 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 260 | 99 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 112 | 107 |
| Established patient office or other outpatient visit, 30-39 minutes | 110 | 74 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 103 | 101 |
| Established patient office or other outpatient visit, 20-29 minutes | 30 | 25 |
| New patient office or other outpatient visit, 45-59 minutes | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Daptomycin | 82 |
| Ertapenem (ertapenem sodium) | 63 |
| Vancomycin Hcl | 59 |
| Meropenem | 43 |
| Doxycycline Hyclate Other prescribers in Jacksonville, FL | 41 |
| Ceftazidime | 29 |
| Ceftriaxone (ceftriaxone sodium) Other prescribers in Jacksonville, FL | 29 |
| Azithromycin Other prescribers in Jacksonville, FL | 25 |
| Amoxicillin-Clavulanate Potass (amoxicillin/potassium clav) Other prescribers in Jacksonville, FL | 20 |
| Ethambutol Hcl | 16 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 10 companies reported 33 payments worth $966 in total to this clinician.
| AbbVie Inc. | $277 |
|---|---|
| Merck Sharp & Dohme LLC | $157 |
| Gilead Sciences, Inc. | $123 |
| Viiv Healthcare Company | $116 |
| Insmed, Inc. | $82.95 |
| Aimmune Therapeutics, Inc. | $77.75 |
| Melinta Therapeutics, LLC | $69.95 |
| Pfizer Inc. | $26.95 |
| Food and Beverage | $940 |
|---|---|
| Education | $25.70 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC Apr 8, 2025 | Education ZERBAXA · INFECTIOUS DISEASE · in-kind | $25.70 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.